Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.551,01
-5,15%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Viatris Inc (VTRS) Viatris Inc (VTRS) Notizie

Viatris Inc

VTRS
11,57
-0,21 (-1,78%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202422:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
15/4/202414:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
15/4/202412:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
01/4/202412:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
27/3/202411:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
06/3/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202400:11EDGAR2Form 144 - Report of proposed sale of securities
28/2/202413:39EDGAR2Form 8-K - Current report
28/2/202412:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
28/2/202407:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
24/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:18EDGAR2Form 144 - Report of proposed sale of securities
05/2/202412:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
30/1/202422:40EDGAR2Form 8-K/A - Current report: [Amend]
19/1/202412:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
06/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:28EDGAR2Form 144 - Report of proposed sale of securities
21/12/202322:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
16/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:04EDGAR2Form 8-K/A - Current report: [Amend]
15/12/202323:00EDGAR2Form 8-K - Current report
15/12/202322:45PRNUSViatris Continues its Preparations for Phase 2 of its..
15/12/202322:14EDGAR2Form 8-K - Current report
15/12/202322:12EDGAR2Form 8-K - Current report
15/12/202322:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
14/12/202323:31EDGAR2Form 144 - Report of proposed sale of securities
25/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/11/202319:02EDGAR2Form 144 - Report of proposed sale of securities
14/11/202314:00PRNUSViatris to Participate in the Jefferies London Healthcare..
13/11/202314:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
07/11/202322:39EDGAR2Form 8-K - Current report
07/11/202322:02PRNUSViatris Reports Strong Financial and Operational Results for..
03/11/202321:36EDGAR2Form ARS - Annual Report to Security Holders
03/11/202321:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/11/202321:31EDGAR2Form DEF 14A - Other definitive proxy statements
30/10/202314:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
24/10/202322:32EDGAR2Form 8-K - Current report
24/10/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
23/10/202315:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
20/10/202323:18EDGAR2Form 8-K - Current report
20/10/202323:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
18/10/202314:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
10/10/202315:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..
Apertura: 11,74 Min: 11,57 Max: 11,75
Chiusura: 11,78

La tua Cronologia

NASDAQ
VTRS
Viatris
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network